Sherry Fleming

Sherry Fleming is a Professor in the Division of Biology at Kansas State University, specializing in innate immune responses. Her research examines how complement systems and natural antibodies contribute to tissue damage during trauma, ischemia/reperfusion, and autoimmune conditions.

The Fleming Lab focuses on the detrimental effects of innate immunity in models of tissue injury, particularly intestinal ischemia/reperfusion. Current work investigates therapeutic peptides targeting beta2 glycoprotein I to mitigate tissue damage. Research spans molecular mechanisms of complement activation, sex differences in immune responses, and translational applications of immunomodulatory therapies.

Fleming's publication record demonstrates consistent contributions to understanding immune-mediated tissue injury, with recent work exploring nanoparticle applications for targeted therapy, sex-specific immune responses, and complement activation pathways in pregnancy disorders like preeclampsia.